Alvimopan: An oral, peripherally acting, μ-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction—A 21-day treatment-randomized clinical trial
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Pain
Authors: Daniel M. Paulson, Daniel T. Kennedy, Roger A. Donovick, Randall L. Carpenter, Maryann Cherubini, Lee Techner, Wei Du, Yuju Ma, William K. Schmidt, Bruce Wallin, David Jackson
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2084196341
